Safety data sheet
Standardized safety protocols and material specifications for professional use.
Certificate of Analysis
Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-ghrp-6-10mg
GHRP-6 (10mg)
Research Grade >99% Purity
Authorized Resellers
Available through our trusted partners
123peptide.com
Netherlands · Europe
local_shipping2-3 Business Days
Depeptidenwinkel.com
Netherlands · Europe
local_shipping2-3 Business Days
What is GHRP-6 Peptide?
GHRP-6 (Growth Hormone-Releasing Peptide-6) is a synthetic hexapeptide that acts as a potent ghrelin receptor agonist (GHS-R1a). It stimulates pulsatile release of endogenous growth hormone from the pituitary while preserving natural feedback loops. Researched for supporting muscle growth, accelerating recovery, improving sleep architecture, enhancing appetite, and providing neuroprotective and cardioprotective benefits.
GHRP-6 binds to the ghrelin receptor (GHS-R1a) in the pituitary and hypothalamus, triggering acute GH release while simultaneously reducing somatostatin tone. Unlike exogenous GH, it maintains physiological pulse patterns — GH and IGF-1 rise naturally, and feedback mechanisms prevent excessive elevation. Beyond endocrine effects, GHRP-6 activates CD36 receptors on immune and muscle cells, initiating PI3K/Akt survival signaling that protects tissues from oxidative stress and inflammation.
Reconstitute the 10 mg vial with 3.0 mL bacteriostatic water for ~3.33 mg/mL (1 unit ≈ 33.3 mcg on U-100 syringes). Standard dosing is 100–300 mcg per injection, three times daily on an empty stomach, spaced at least 4 hours apart.
Intended Research Use
- Stimulates strong, pulsatile GH release and elevates IGF-1 levels
- Accelerates muscle repair, reduces inflammation, and supports hypertrophy
- Enhances slow-wave sleep and overall recovery
- Increases appetite and nutrient partitioning for lean mass gains
- Provides neuroprotection, cardioprotection, and anti-fibrotic effects
- Memory consolidation and cognitive enhancement via GHSR activation
menu_bookScientific Publications
Clin Sci Lond (2007)
Growth-hormone-releasing peptide 6 (GHRP6) prevents oxidant cytotoxicity and reduces myocardial necrosis in a model of acute myocardial infarction
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/16928199/
Plast Surg Int (2016)
Growth Hormone-Releasing Peptide 6 Enhances the Healing Process and Improves the Esthetic Outcome of the Wounds
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/27200188/
Mol Brain (2018)
Down-regulation of ghrelin receptors on dopaminergic neurons in the substantia nigra contributes to Parkinson's disease-like motor dysfunction
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29391028/
Neurol Res (2016)
Assessment of dose-effect and therapeutic time window in preclinical studies of rhEGF and GHRP-6 coadministration for stroke therapy
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/26894658/
Int Wound J (2018)
Growth hormone-releasing peptide 6 prevents cutaneous hypertrophic scarring: early mechanistic data from a proteome study
open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29457313/
FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.
Possible stacks with other peptides
Synergistic combinations for enhanced research outcomes
CJC-1295 No DAC (2mg vial)
arrow_forwardmyo-cjc-1295-no-dac-2mg
Frequently researched for synergistic GHRH/GHS effects on GH pulses, supporting lean mass and fat loss in metabolic models.
Ipamorelin (5mg vial)
arrow_forwardmyo-ipamorelin-5mg
Explored for selective GH release without strong appetite stimulation — ideal for recovery and anti-aging inquiries.
BPC-157 (5mg vial)
arrow_forwardmyo-bpc-157-5mg
Investigated for joint tissue protection and healing synergy, enhancing neuroprotective and anti-fibrotic properties in injury models.
GHRP-2 5mg (5mg vial)
arrow_forwardmyo-ghrp-2-5mg
More potent GH-releasing peptide with stronger pulse amplitude — studied alongside GHRP-6 for comparative secretagogue potency and appetite stimulation profiles.
Cycling Note: Cycle these stacks in 8–12 week periods with off-times to sustain efficacy, as prolonged GHS exposure could lead to receptor desensitization in endocrine models.